MNEXSPIKE is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). MNEXSPIKE is approved for use in individuals who are:
65 years of age and older, or
12 years through 64 years of age with
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Agde1PD
No comments:
Post a Comment